EF Hutton analyst Constantine Davides reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $7 price target.
Etsy Q3 Earnings: EPS Beat, Revenue Up 7% Amid ‘Challenging Environment’ For Discretionary Spending
Etsy Inc (NASDAQ: ETSY) reported third-quarter financial results on Wednesday.